Robert Giasolli
Fundador en Cagent Vascular, Inc. .
Perfil
Robert Mero Giasolli is the founder of Innovasc LLC founded in 2007, Intact Vascular, Inc. founded in 2011, and Cagent Vascular, Inc. founded in 2014.
At Intact Vascular, Inc., he held the title of CTO, Vice President-Research & Development from 2011 to 2014.
At Cagent Vascular, Inc., he holds the title of Chief Technology Officer & VP Clinical Engineering since 2014.
Currently, he is Vice President-American Region at Micro & Nanotechnology Commercialization Education Foundation.
Mr. Giasolli has a graduate degree from Louisiana Tech University and an undergraduate degree from the University of Texas at El Paso.
Cargos activos de Robert Giasolli
| Empresas | Cargo | Inicio |
|---|---|---|
| Micro & Nanotechnology Commercialization Education Foundation | Corporate Officer/Principal | - |
Cagent Vascular, Inc.
 Cagent Vascular, Inc. Medical SpecialtiesHealth Technology Cagent Vascular LLC engages in manufacturing medical instruments. The company was founded by Carol Burns, Robert Giasolli and Peter Schneider and is headquartered in Wayne, PA. | Fundador | 01/01/2014 |
Antiguos cargos conocidos de Robert Giasolli.
| Empresas | Cargo | Fin |
|---|---|---|
Innovasc LLC
 Innovasc LLC Pharmaceuticals: OtherHealth Technology Innovasc LLC provides a treatment platform comprised of two devices that enable drug-eluting balloon therapy. It focuses on the development of alternatives to stent technology. The firm's products permit minimal injury balloon angioplasty and minimal footprint tacking of blood vessel blockages. The company was founded by Peter Schneider and Robert Giasolli in 2007 and is headquartered in Honolulu, HI. | Fundador | - |
Intact Vascular, Inc.
 Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | Fundador | - |
Formación de Robert Giasolli.
| Louisiana Tech University | Graduate Degree |
| University of Texas at El Paso | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Innovasc LLC
Innovasc LLC Pharmaceuticals: OtherHealth Technology Innovasc LLC provides a treatment platform comprised of two devices that enable drug-eluting balloon therapy. It focuses on the development of alternatives to stent technology. The firm's products permit minimal injury balloon angioplasty and minimal footprint tacking of blood vessel blockages. The company was founded by Peter Schneider and Robert Giasolli in 2007 and is headquartered in Honolulu, HI. | Health Technology |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | Health Technology |
Cagent Vascular, Inc.
Cagent Vascular, Inc. Medical SpecialtiesHealth Technology Cagent Vascular LLC engages in manufacturing medical instruments. The company was founded by Carol Burns, Robert Giasolli and Peter Schneider and is headquartered in Wayne, PA. | Health Technology |
| Micro & Nanotechnology Commercialization Education Foundation |
- Bolsa de valores
- Insiders
- Robert Giasolli
